Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 516

1.

Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.

Falagas ME, Barefoot L, Griffith J, Ruthazar R, Snydman DR.

Eur J Clin Microbiol Infect Dis. 1996 Dec;15(12):913-21.

PMID:
9031873
2.
3.

Pharmacoeconomic analysis of ampicillin-sulbactam versus cefoxitin in the treatment of intraabdominal infections.

Messick CR, Mamdani M, McNicholl IR, Danziger LH, Rodvold KA, Condon RE, Walker AP, Edmiston CE Jr.

Pharmacotherapy. 1998 Jan-Feb;18(1):175-83. Erratum in: Pharmacotherapy 1998 May-Jun;18(3):662.

PMID:
9469691
8.

Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.

Brook I.

Clin Infect Dis. 1995 Jun;20 Suppl 2:S376-7. No abstract available.

PMID:
7548603
9.
10.

Critical issues in the clinical management of complicated intra-abdominal infections.

Blot S, De Waele JJ.

Drugs. 2005;65(12):1611-20. Review.

PMID:
16060697
11.

Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients.

Kaye KS, Harris AD, Gold H, Carmeli Y.

Antimicrob Agents Chemother. 2000 Apr;44(4):1004-9.

12.

Comparative study of cefotetan and cefoxitin in the treatment of intra-abdominal infections.

Lewis RT, Duma RJ, Echols RM, Jemsek JG, Najem AZ, Press RA, Stone HH, Ton GT, Wilson SE.

Am J Obstet Gynecol. 1988 Mar;158(3 Pt 2):728-35. Erratum in: Am J Obstet Gynecol 1989 Apr;160(4):1025.

PMID:
3281463
13.

Abdominal surgical wound infection is lowered with improved perioperative enterococcus and bacteroides therapy.

Weigelt JA, Easley SM, Thal ER, Palmer LD, Newman VS.

J Trauma. 1993 Apr;34(4):579-84; discussion 584-5.

PMID:
8487344
14.

Cost-effectiveness study of cefotetan versus cefoxitin and cefotetan versus combination antibiotic regimens.

Sochalski A, Sullman S, Andriole VT.

Am J Surg. 1988 May 31;155(5A):96-101.

PMID:
3132048
15.

Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.

Stryjewski ME, O'Riordan WD, Lau WK, Pien FD, Dunbar LM, Vallee M, Fowler VG Jr, Chu VH, Spencer E, Barriere SL, Kitt MM, Cabell CH, Corey GR; FAST Investigator Group.

Clin Infect Dis. 2005 Jun 1;40(11):1601-7. Epub 2005 Apr 28.

16.

Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.

Walker AP, Nichols RL, Wilson RF, Bivens BA, Trunkey DD, Edmiston CE Jr, Smith JW, Condon RE.

Ann Surg. 1993 Feb;217(2):115-21.

17.

Tigecycline: a glycylcycline antimicrobial agent.

Doan TL, Fung HB, Mehta D, Riska PF.

Clin Ther. 2006 Aug;28(8):1079-106. Review.

PMID:
16982286
18.

Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?

CaĆ­nzos M.

Clin Microbiol Infect. 2008 Dec;14 Suppl 6:9-18. doi: 10.1111/j.1469-0691.2008.02123.x. Review.

19.

Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.

McMillian WD, Bednarik JL, Aloi JJ, Ahern JW, Crookes BA.

J Trauma. 2010 Oct;69(4):861-5. doi: 10.1097/TA.0b013e3181e83f8b.

PMID:
20938272
20.

Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.

Lucasti C, Jasovich A, Umeh O, Jiang J, Kaniga K, Friedland I.

Clin Ther. 2008 May;30(5):868-83. doi: 10.1016/j.clinthera.2008.04.019.

PMID:
18555934
Items per page

Supplemental Content

Write to the Help Desk